CClinicalTrials.gg
CompletedNCT06709781Updated Jun 24, 2026

Cardiovascular Responses in Burn Survivors During Exercise

An interventional study of Control (no cooling modalities) and Water Spray in Burn Injury, sponsored by University of Texas Southwestern Medical Center. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-24.

Sponsored by University of Texas Southwestern Medical Center · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
31
Allocation
Non-randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This project will identify the efficacy of cooling modalities aimed to attenuate excessive elevations in skin and internal body temperatures, and associated indices of cardiovascular stress, during physical activity in well-healed burn survivors. The investigators will conduct a randomized crossover design study. Non-burned control subjects and subjects who experienced burns covering 20% or more of their body surface area will be investigated. Subjects will exercise in heated environmental conditions while receiving no cooling (control) as well as skin wetting.

Read the detailed description

Within the United States, 500,000+ individuals are enduring the long-term consequences of severe burn injuries covering 20% or more of their body surface area, with upwards to 11,000 individuals experiencing such an injury per year. These burn injuries can severely compromise body temperature regulation, owing to permanent impairments in the primary thermoeffectors necessary to dissipate heat, namely profoundly blunted skin blood flow and sweating responses in the injured skin. The investigators propose that this heat intolerance deters burn survivors from participating in physical activity, including activities of daily living, necessary to avoid the adverse cardiovascular and metabolic sequela of a sedentary lifestyle. Consistent with hypothesis, years after the injury burn survivors have a very low aerobic capacity; greater all-cause mortality rates; greater hospitalization days for circulatory diseases; and suffer from greater incidences of ischemic heart disease, heart failure, diabetes, and cerebrovascular disease (including stroke) relative to matched non-burned cohorts. The primary goal of this project is to identify modalities to attenuate excessive elevations in skin and core body temperatures, and accompanying cardiovascular stress, during physical activity in well-healed burn survivors. The implementation of such modalities will eliminate heat intolerance as a barrier to participation in activities that are necessary to improve/maintain cardiovascular health in this vulnerable population. This project will investigate whether increased skin wetness will restore otherwise impaired evaporative cooling of well-healed burn survivors, with the extent of that improvement predicated on the environmental conditions and the percentage of body surface area burned.

02

Conditions studied

  • Burn Injury

Browse trials for

Keywords

  • skin graft
  • thermoregulation
  • burn survivor
  • 3rd degree burn injury
  • human
  • cooling
03

In context

Burns

719 studies on the registry are indexed under Burns; 145 are open to participants now.

This study's enrollment of 31 is below the median of 40 across 524 interventional studies indexed under Burns.

Browse Burns studies →

Lead sponsor

University of Texas Southwestern Medical Center is the lead sponsor of 990 studies on the registry; 201 are open to participants now.

Of its 135 completed or terminated interventional studies of FDA-regulated products, 100 (74%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria: Non-Burned Individuals

  • Healthy male and female subjects
  • 18-65 years of age.
  • Free of any underlying medical conditions

Exclusion Criteria: Non-Burned Individuals

  • Any burn-related injuries resulting in at least one night of hospitalization.
  • Heart disease or any other chronic medical condition requiring regular medical therapy including cancer, diabetes, and hypertension.
  • Abnormalities detected on routine screening
  • Individuals who participate in a structured aerobic exercise training program at moderate to high intensities.
  • Current smokers, as well as individuals who regularly smoked within the past 3 years.
  • Body mass index of greater than 30 kg/m\^2.
  • Pregnant individuals

Inclusion Criteria: Burn Survivors

  • Healthy male and female subjects
  • 18-65 years of age.
  • Free of any underlying medical conditions
  • Having a burn injury covering 20% or more of the participant's body surface area; at least 50% of those burn injuries must be full thickness that required skin grafting.
  • Participants must have been hospitalized due to the burn injury for a minimum of 15 days

Exclusion Criteria: Burn Survivors

  • Any burn-related injuries resulting in at least one night of hospitalization.
  • Heart disease or any other chronic medical condition requiring regular medical therapy including cancer, diabetes, and hypertension.
  • Abnormalities detected on routine screening
  • Individuals who participate in a structured aerobic exercise training program at moderate to high intensities.
  • Current smokers, as well as individuals who regularly smoked within the past 3 years.
  • Body mass index of greater than 30 kg/m\^2.
  • Pregnant individuals
  • Extensive unhealed injured skin
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
31 participants (actual)

Study arms

  • Experimental
    Non-Burned Individuals

    Non-burned individuals will exercise for 60 minutes in the heat while being exposed to either no cooling or cooling via skin wetting (two trials).

    Other: Control (no cooling modalities) · Other: Water Spray

  • Experimental
    Burn Survivors (20% or more Burn Surface Area burn-injured)

    Burn survivors with 20% or more BSA (burn surface area) burn-injured will exercise for 60 in the heat while being exposed to either no cooling or cooling via skin wetting (two trials).

    Other: Control (no cooling modalities) · Other: Water Spray

Interventions

  • OtherControl (no cooling modalities)

    Subjects will exercise for 60 minutes in the heat while being exposed to no cooling modality.

  • OtherWater Spray

    Subjects will exercise for 60 minutes in the heat while being exposed to skin wetting. Skin wetting will be performed by spraying water onto the skin throughout the exercise bout.

06

What researchers measure

Primary outcomes

  1. Change in Core Temperature (°C) During Control Intervention

    The subject's core body temperature will be measured from gastrointestinal or rectal temperature measures.

    Time frame: At 0 minutes and 60 minutes into the intervention.

  2. Change in Core Temperature (°C) During Water-Spray Intervention

    The subject's core body temperature will be measured from gastrointestinal or rectal temperature measures.

    Time frame: At 0 minutes and 60 minutes into the intervention.

Secondary outcomes

  1. Skin Temperature (°C) Following Control Intervention

    The subject's skin temperature will be measured from small temperature sensitive electrodes attached to the participant's skin.

    Time frame: At 60 minutes into the intervention.

  2. Skin Temperature (°C) Following Water-Spray Intervention

    The subject's skin temperature will be measured from small temperature sensitive electrodes attached to the participant's skin.

    Time frame: At 60 minutes into the intervention.

  3. Heart Rate Following Control Intervention

    The subject's heart rate will be measured from ECG electrodes attached to the participant.

    Time frame: At 60 minutes into the intervention.

  4. Heart Rate Following Water-Spray Intervention

    The subject's heart rate will be measured from ECG electrodes attached to the participant.

    Time frame: At 60 minutes into the intervention.

  5. Mean Arterial Blood Pressure Following Control Intervention

    The subject's mean arterial blood pressure will be measured using a standard arm blood pressure cuff. Mean Arterial Pressure (MAP) is a common physiological measure calculated by adding the diastolic blood pressure value to one third of the difference between the systolic (SBP) and diastolic (DBP) blood pressure values. MAP = DBP + 1/3(SBP - DBP)

    Time frame: At 60 minutes into the intervention.

  6. Mean Arterial Blood Pressure Following Water-Spray Intervention

    The subject's mean arterial blood pressure will be measured using a standard arm blood pressure cuff. Mean Arterial Pressure (MAP) is a common physiological measure calculated by adding the diastolic blood pressure value to one third of the difference between the systolic (SBP) and diastolic (DBP) blood pressure values. MAP = DBP + 1/3(SBP - DBP)

    Time frame: At 60 minutes into the intervention.

07

Study locations

1 site
  • Institute for Exercise and Environmental Medicine - Texas Health Presbyterian Hospital Dallas
    Dallas, Texas 75231, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06709781
Lead sponsor
University of Texas Southwestern Medical Center
Responsible party
Craig Crandall (Professor of Internal Medicine, University of Texas Southwestern Medical Center) — Principal investigator
First posted
Nov 29, 2024
Start date
Jan 8, 2025
Primary completion
Sep 5, 2025
Completion
Sep 5, 2025
Last update
Jun 24, 2026

Study contacts

Craig G Crandall, PhD
principal investigator · University of Texas Southwestern Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion